Identification of the cystic fibrosis transmembrane conductance regulator domains that are important for interactions with ROMK2

被引:19
作者
Cahill, P
Nason, MW
Ambrose, C
Yao, TY
Thomas, P
Egan, ME
机构
[1] Yale Univ, Sch Med, Dept Pediat, Div Resp Med, New Haven, CT 06520 USA
[2] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA
关键词
D O I
10.1074/jbc.M910205199
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In addition to functioning as a cAMP-activated chloride channel, the cystic fibrosis transmembrane conductance regulator (CFTR) plays an important role in conferring regulatory properties on other ion channels. It is known, with respect to CFTR regulation of ROMK2 (renally derived K-ATP channel), that the first transmembrane domain and the first nucleotide binding fold domain (NBF1) of CFTR are necessary for this interaction to occur. It has been shown that under conditions that promote phosphorylation, the ROMK2-CFTR interaction is attenuated. To elucidate the complex nature of this interaction, CFTR constructs were co-expressed with ROMK2 in Xenopus oocytes, and two microelectrode voltage clamp experiments were performed. Although the second half of CFTR can act as a functional chloride channel, our results suggest that it does not confer glibenclamide sensitivity on ROMK2, as does the first half of CFTR. The attenuation of the ROMK2-CFTR interaction under conditions that promote phosphorylation is dependent on at least the presence of the R domain of CFTR. We conclude that transmembrane domain 1, NBF1, and the R domain are the CFTR domains involved in the ROMK2-CFTR interaction and that NBF2 and transmembrane domain 2 are not essential. Lastly, the R domain of CFTR is necessary for the attenuation of the ROMK2-CFTR interaction under conditions that promote phosphorylation.
引用
收藏
页码:16697 / 16701
页数:5
相关论文
共 29 条
  • [11] RECONSTITUTION OF I-KATP - AN INWARD RECTIFIER SUBUNIT PLUS THE SULFONYLUREA RECEPTOR
    INAGAKI, N
    GONOI, T
    CLEMENT, JP
    NAMBA, N
    INAZAWA, J
    GONZALEZ, G
    AGUILARBRYAN, L
    SEINO, S
    BRYAN, J
    [J]. SCIENCE, 1995, 270 (5239) : 1166 - 1170
  • [12] KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367
  • [13] Inhibition of epithelial Na+ currents by intracellular domains of the cystic fibrosis transmembrane conductance regulator
    Kunzelmann, K
    Kiser, GL
    Schreiber, R
    Riordan, JR
    [J]. FEBS LETTERS, 1997, 400 (03) : 341 - 344
  • [14] Wild type but not Delta F508 CFTR inhibits Na+ conductance when coexpressed in Xenopus oocytes
    Mall, M
    Hipper, A
    Greger, R
    Kunzelmann, K
    [J]. FEBS LETTERS, 1996, 381 (1-2) : 47 - 52
  • [15] Sensitivity of a renal K+ channel (ROMK2) to the inhibitory sulfonylurea compound glibenclamide is enhanced by coexpression with the ATP-binding cassette transporter cystic fibrosis transmembrane regulator
    McNicholas, CM
    Guggino, WB
    Schwiebert, EM
    Hebert, SC
    Giebisch, G
    Egan, ME
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) : 8083 - 8088
  • [16] A functional CFTR-NBF1 is required for ROMK2-CFTR interaction
    McNicholas, CM
    Nason, MW
    Guggino, WB
    Schwiebert, EM
    Hebert, SC
    Giebisch, G
    Egan, ME
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1997, 273 (05) : F843 - F848
  • [17] Both the wild type and a functional isoform of CFTR are expressed in kidney
    Morales, MM
    Carroll, TP
    Morita, T
    Schwiebert, EM
    Devuyst, O
    Wilson, PD
    Lopes, AG
    Stanton, BA
    Dietz, HC
    Cutting, GR
    Guggino, WB
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1996, 270 (06) : F1038 - F1048
  • [18] NASON MW, 1997, PEDIAT PULM S14, V217
  • [19] PIAZZACARROLL T, 1994, CELL PHYSIOL BIOCHEM, V4, P10
  • [20] RIORDAN JR, 1989, SCIENCE, V245, P1066